JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

Search

Omnicell Inc

Fechado

SetorSaúde

48.95 -1.98

Visão Geral

Variação de preço das ações

24h

Atual

Mín

48.55

Máximo

50.37

Indicadores-chave

By Trading Economics

Rendimento

-177K

5.5M

Vendas

20M

311M

P/E

Médio do Setor

117.023

90.422

EPS

0.51

Margem de lucro

1.758

Funcionários

3,600

EBITDA

524K

31M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+11.29% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

909M

2.3B

Abertura anterior

50.93

Fecho anterior

48.95

Sentimento de Notícias

By Acuity

50%

50%

148 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de jan. de 2026, 23:07 UTC

Ganhos

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27 de jan. de 2026, 21:27 UTC

Ganhos

Texas Instruments 4Q Sales Rise, Profit Falls

27 de jan. de 2026, 23:55 UTC

Conversa de Mercado

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27 de jan. de 2026, 23:47 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 de jan. de 2026, 23:47 UTC

Conversa de Mercado

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27 de jan. de 2026, 23:39 UTC

Conversa de Mercado

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27 de jan. de 2026, 23:20 UTC

Ganhos

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27 de jan. de 2026, 23:20 UTC

Ganhos

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27 de jan. de 2026, 23:19 UTC

Ganhos

SK Innovation Posts Net Loss for Second Consecutive Year

27 de jan. de 2026, 23:19 UTC

Ganhos

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27 de jan. de 2026, 23:18 UTC

Ganhos

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27 de jan. de 2026, 23:18 UTC

Ganhos

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27 de jan. de 2026, 23:11 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

27 de jan. de 2026, 23:11 UTC

Conversa de Mercado

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27 de jan. de 2026, 23:07 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27 de jan. de 2026, 22:17 UTC

Conversa de Mercado

U.S. Dollar Slips Following Trump Comments -- Market Talk

27 de jan. de 2026, 22:06 UTC

Ganhos

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27 de jan. de 2026, 21:51 UTC

Ganhos

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

27 de jan. de 2026, 21:43 UTC

Ganhos

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27 de jan. de 2026, 21:41 UTC

Ganhos

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27 de jan. de 2026, 21:38 UTC

Ganhos

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27 de jan. de 2026, 21:32 UTC

Ganhos

Ampol: Modest Profit From F&I International in 2025

27 de jan. de 2026, 21:32 UTC

Ganhos

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27 de jan. de 2026, 21:31 UTC

Ganhos

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27 de jan. de 2026, 21:31 UTC

Ganhos

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27 de jan. de 2026, 21:30 UTC

Ganhos

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27 de jan. de 2026, 21:29 UTC

Ganhos

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27 de jan. de 2026, 21:29 UTC

Ganhos

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27 de jan. de 2026, 21:28 UTC

Ganhos

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

11.29% parte superior

Previsão para 12 meses

Média 55.6 USD  11.29%

Máximo 63 USD

Mínimo 50 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

5

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

148 / 352 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat